Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients.

Hendra SetiadiAhmed M El-BanayosyJames W LongMarc O MaybauerMircea R MihuAly El Banayosy

Published in: Artificial organs (2023)

These early findings suggested critical value of absolute and relative pOSM to characterize the inflammatory burden of ARDS patients and the outcome of their V-V ECMO support.

Keyphrases

end stage renal disease
acute respiratory distress syndrome
extracorporeal membrane oxygenation
ejection fraction
chronic kidney disease
peritoneal dialysis
patient reported outcomes
risk factors
intensive care unit